These findings support a model in which sEVs enriched in miR‐17/20a‐5p alleviate CCH‐induced synaptic impairment and cognitive dysfunction by activating the mTOR pathway through DEPTOR suppression. The gene discussed is DEPTOR; the disease is columnar cell hyperplasia of the breast.